Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Clements

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
NPJ Vaccines|October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigenNeal Van Hoeven, Steven Wiley, Emily Gage, et al.
Plos One|February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsNeal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
Vaccine: X|November 15, 2021
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceChih-Yun Lai, Albert To, Teri Ann S Wong, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Vaccine|September 26, 2006
Preparation and immunogenic properties of a recombinant West Nile subunit vaccineMichael M Lieberman, David E Clements, Steven Ogata, et al.
Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
NPJ Vaccines|October 11, 2018
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigenNeal Van Hoeven, Steven Wiley, Emily Gage, et al.
Plos One|February 23, 2016
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple FormulationsNeal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, et al.
Vaccine: X|November 15, 2021
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceChih-Yun Lai, Albert To, Teri Ann S Wong, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Vaccine|September 26, 2006
Preparation and immunogenic properties of a recombinant West Nile subunit vaccineMichael M Lieberman, David E Clements, Steven Ogata, et al.
Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.
Pageof 2